Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Efeitos Contextuais nos Biomarcadores Inflamatórios e Alívio da Dor Após Manipulação das Articulações Vertebrais (CONTEXT-PAIN)

12 de outubro de 2026 atualizado por: John Paul II University in Biała Podlaska

A Influência dos Efeitos Contextuais nos Parâmetros Bioquímicos Associados à Inflamação e à Eficácia Analgésica da Terapia de Manipulação das Articulações Vertebrais

The goal of this clinical trial is to learn whether contextual effects created by observational learning can change pain relief and inflammation-related biological responses after spinal joint manipulation in adults with chronic non-specific low back pain. The main questions it aims to answer are:

Does positive, neutral, or negative observational learning change pain after spinal joint manipulation? Does it change disability, lumbar range of motion, stress, fear of movement, empathy, and treatment expectations? Does it change pressure pain threshold, lumbar tissue temperature, and blood markers related to inflammation, including interleukin-6 (IL-6), high-sensitivity C-reactive protein (hs-CRP), tumor necrosis factor alpha (TNF-α), and interleukin-10 (IL-10)?

The researchers will compare 3 groups: a positive expectation group, a neutral group, and a negative expectation group. Before the treatment, each participant will have a short interaction with a trained simulated patient. The simulated patient will present a positive, neutral, or negative experience with spinal manipulation, depending on group assignment. After this, all the participants will receive the same spinal joint manipulation procedure.

The participants will:

  • be randomly assigned to 1 of 3 study groups,
  • complete baseline questionnaires and clinical tests before treatment,
  • take part in a brief observational learning session before manipulation,
  • receive 1 spinal joint manipulation treatment,
  • complete outcome measurements before treatment, about 60 minutes after treatment, and 24 hours after treatment,
  • provide blood samples for analysis of inflammation-related biomarkers.

This study will include adults aged 18 to 65 years with chronic non-specific low back pain. The main outcome is pain intensity. Secondary outcomes include disability, stress, empathy, fear of movement, lumbar range of motion, tissue temperature, pressure pain threshold, and treatment expectations. Exploratory outcomes include blood biomarkers related to inflammation.

Visão geral do estudo

Status

Concluído

Condições

Intervenção / Tratamento

Descrição detalhada

Chronic non-specific low back pain is a common and disabling condition. Spinal joint manipulation is frequently used in its management, but the mechanisms underlying its effects are not fully understood. Increasing attention has been given to contextual factors, including treatment expectations, which may influence pain-related outcomes through psychological and neurophysiological pathways. One potentially important mechanism is observational learning, in which expectations are shaped by observing another person's experience with treatment. This mechanism has been studied in experimental pain settings, but it has been investigated only rarely in clinical populations and has not been adequately tested in the context of spinal manipulation for chronic non-specific low back pain.

The purpose of this study is to evaluate whether observational learning before treatment can modify the effects of spinal joint manipulation in adults with chronic non-specific low back pain. The trial is designed to examine whether a brief peer-modeling interaction presented before treatment can influence clinical outcomes, psychological responses, and selected mechanistic measures, including inflammatory biomarkers. The study will compare positive, neutral, and negative observational learning conditions to determine whether expectation-related contextual effects alter response to the same manual therapy procedure.

This study is a prospective, parallel-group, three-arm randomized controlled trial with follow-up assessment. The participants will be randomly assigned in a 1:1:1 ratio to one of three groups: positive observational learning, neutral observational learning, or negative observational learning. The target analyzed sample is 66 participants, and the recruitment target has been increased to 73 participants to account for possible dropout. Allocation concealment will be ensured using opaque, sequentially numbered envelopes prepared by an independent researcher. The participants, treating physiotherapists, outcome assessors, and statisticians will remain blinded to group allocation and study hypotheses throughout the trial.

The participants will be adults aged 18 to 65 years with chronic non-specific low back pain lasting more than 3 months and pain intensity of at least 4 out of 10 during the previous 24 hours. Eligibility will be based on clinical criteria for chronic non-specific low back pain. Key exclusion criteria include prior spinal manipulation, major spinal red flags, recent lumbar trauma or surgery, selected systemic or psychiatric conditions, pregnancy, active infection, relevant medication use that could affect pain or inflammatory responses, and factors that could interfere with understanding the observational learning procedure. A screening log will be maintained to document exclusions and reasons for non-enrollment.

All the participants will undergo the same spinal manipulation intervention. The manipulation will be delivered as a high-velocity, low-amplitude lumbar technique. The procedure will be applied on the symptomatic side identified by the participant; if the participant cannot identify the more symptomatic side, the physiotherapist will decide. If cavitation is not obtained, the physiotherapist may attempt the procedure on the opposite side. A maximum of two attempts per side will be allowed. This approach is intended to standardize the specific treatment component across all study groups.

The contextual manipulation will be delivered before the spinal manipulation through a one-time observational learning procedure. After completion of baseline assessments, each participant will take part in a brief standardized consultation in a waiting-room setting. The main researcher will provide neutral information about the spinal manipulation program and then briefly leave the room. A trained simulated patient will then enter and deliver a scripted interaction corresponding to the assigned study group. In the positive observational learning group, the simulated patient will describe clear improvement in low back pain and mobility after spinal manipulation and will reinforce this message by demonstrating comfortable lumbar movement. In the neutral group, the simulated patient will not comment on treatment effects and will only have a brief neutral interaction. In the negative observational learning group, the simulated patient will report little or no improvement and will reinforce this message by demonstrating limited lumbar movement with visible discomfort. Simulated patients will be trained to standardize tone of voice, body language, facial expression, and timing of the interaction. The female participants will interact with the female simulated patients, and the male participants will interact with the male simulated patients.

Data will be collected at baseline before treatment (T0), approximately 60 minutes after spinal manipulation (T1), and 24 hours after spinal manipulation (T2). Expected benefit will be assessed both at baseline and immediately after the observational learning interaction in order to evaluate whether the contextual manipulation changed treatment expectations. Fulfillment of expectations will be assessed after treatment and again at 24 hours. The primary endpoint is pain intensity. Secondary measures include pressure pain threshold, perceived stress, empathy, kinesiophobia, disability, lumbar range of motion, lumbar tissue temperature, expected benefit, fulfillment of expectations, attitude toward manual therapy, and treatment satisfaction. Exploratory outcomes include blood biomarkers related to inflammation.

Blood samples will be collected by qualified personnel under standardized conditions. To reduce variability, blood draws will be scheduled in the morning after fasting, and participants will receive instructions regarding restrictions on intense physical activity, caffeine, alcohol, nicotine, and analgesic or anti-inflammatory medication before sampling. Samples will be processed according to standard laboratory procedures, aliquoted, and stored at minus 80 degrees Celsius until analysis. Laboratory analyses will include interleukin-6 (IL-6), high-sensitivity C-reactive protein (hs-CRP), tumor necrosis factor alpha (TNF-α), and interleukin-10 (IL-10). When feasible, assays will be performed using electrochemiluminescence multiplex methods; if this is not available, enzyme-linked immunosorbent assay methods will be used. Samples will be analyzed in duplicate with plate controls to monitor assay variability.

The study is intended to provide an integrated evaluation of how expectation-related contextual effects may influence response to spinal joint manipulation. By combining clinical, psychological, and biological outcomes, the trial seeks to clarify whether observational learning is a modifiable mechanism that can enhance or reduce treatment response in people with chronic non-specific low back pain. The underlying hypothesis is that positive observational learning will lead to more favorable outcomes than neutral or negative observational learning.

Statistical analyses will follow the intention-to-treat principle, with a per-protocol analysis conducted as a sensitivity analysis. Repeated measurements over time will be analyzed using mixed models with study group and time as factors, including the group-by-time interaction and baseline value as a covariate when appropriate. Prespecified contrasts will compare positive versus neutral, negative versus neutral, and positive versus negative conditions. Secondary outcomes will be analyzed with adjustment for multiplicity within comparison families. Exploratory biomarker analyses will emphasize effect estimates and confidence intervals. Missing data will be described, and mixed-model estimation will use all available observations under a missing-at-random assumption.

Participation in the study is voluntary and requires written informed consent. Ethics approval will be obtained from the Bioethics Committee at the John Paul II University in Biała Podlaska before recruitment begins. Because the study includes an expectation-based procedure using a simulated patient, full disclosure of the specific study aims and hypotheses will be provided to participants after completion of the study, in accordance with the ethical approach described in the protocol.

Tipo de estudo

Intervencional

Inscrição (Real)

72

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • Lublin Voivodeship
      • Biała Podlaska, Lublin Voivodeship, Polônia, 21-500
        • John Paul II University in Biała Podlaska
      • Biała Podlaska, Lublin Voivodeship, Polônia, 21-500
        • Laboratory of the John Paul II University in Biała Podlaska

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos a 65 anos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • people with low back pain lasting longer than 3 months, aged 18 to 65 years,
  • highest reported pain intensity during the last 24 hours of at least 4 out of 10 on the 11-point Numeric Pain Rating Scale (NPRS-11), where 0 = no pain and 10 = worst imaginable pain,
  • clinical diagnosis of chronic non-specific low back pain (NSCLBP) based on symptoms located in the lumbar spine region and not on imaging findings,
  • no use of nonsteroidal anti-inflammatory drugs (NSAIDs) for at least 7 days before the study,
  • no use of pain medication for at least 24 hours before the study,
  • no use of corticosteroids,
  • no previous spinal manipulation therapy,
  • no alcohol, nicotine, or coffee consumption for at least 12 hours before the study,
  • written informed consent to participate in the study.

Exclusion Criteria:

  • physiotherapy students,
  • presence of red flags, such as a history of cancer, constant or non-mechanical pain, progressive or radiating pain, sensory deficits in the trunk or - lower limbs, lower limb muscle weakness, or bladder/bowel dysfunction,
  • body mass index (BMI) greater than 30,
  • previous lumbar spine surgery,
  • lumbar spine injury within 6 months before the study,
  • diagnosed diabetes,
  • diagnosed rheumatic diseases,
  • affective disorders such as post-traumatic stress disorder (PTSD) or schizophrenia,
  • spondylolisthesis or spondylolysis confirmed by imaging,
  • diagnosed endometriosis,
  • use of hormonal medications,
  • sleep disorders,
  • shift work,
  • musculoskeletal injury within the last 14 days,
  • active infection,
  • pregnancy,
  • endocrine disorders such as hyperthyroidism or hypothyroidism,
  • use of opioid medications, including over-the-counter combination products such as codeine with paracetamol,
  • current or recent use of antidepressants affecting serotonin or dopamine (including SSRIs, SNRIs, tricyclic antidepressants, MAO inhibitors, or ketamine),
  • current diagnosis of major depressive disorder or bipolar disorder, as well as PTSD or schizophrenia,
  • ongoing psychotherapy during the study period,
  • cognitive impairment or significant hearing impairment that may interfere with understanding or processing the observational learning procedure.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Triplo

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Positive Observational Learning + Spinal Joint Manipulation

The participants are exposed to a standardized positive observational learning procedure before treatment. A simulated patient describes clear improvement in low back pain and lumbar mobility after spinal manipulation and demonstrates comfortable lumbar movement. After this interaction, the participants receive the same spinal joint manipulation procedure as in the other study arms.

A standardized pre-treatment observational learning procedure delivered through an interaction with a simulated patient presenting positive, neutral, or negative treatment-related expectations and recovery behavior.

A standardized high-velocity, low-amplitude lumbar spinal manipulation applied after the observational learning procedure in all study arms.

Experimental: Neutral Observational Learning + Spinal Joint Manipulation

The participants are exposed to a standardized neutral observational learning procedure before treatment. A simulated patient has a brief neutral interaction and does not describe treatment effects or demonstrate functional improvement. After this interaction, the participants receive the same spinal joint manipulation procedure as in the other study arms.

A standardized pre-treatment observational learning procedure delivered through an interaction with a simulated patient presenting positive, neutral, or negative treatment-related expectations and recovery behavior.

A standardized high-velocity, low-amplitude lumbar spinal manipulation applied after the observational learning procedure in all study arms.

Experimental: Negative Observational Learning + Spinal Joint Manipulation

The participants are exposed to a standardized negative observational learning procedure before treatment. A simulated patient reports little or no improvement in low back pain after spinal manipulation and demonstrates limited lumbar movement with visible discomfort. After this interaction, the participants receive the same spinal joint manipulation procedure as in the other study arms.

A standardized pre-treatment observational learning procedure delivered through an interaction with a simulated patient presenting positive, neutral, or negative treatment-related expectations and recovery behavior.

A standardized high-velocity, low-amplitude lumbar spinal manipulation applied after the observational learning procedure in all study arms.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Pain intensity score on the 11-point Numeric Pain Rating Scale (NPRS-11)
Prazo: Baseline (pre-intervention), 60 minutes after spinal joint manipulation, and 24 hours after spinal joint manipulation.

Pain intensity will be assessed using the 11-point Numeric Pain Rating Scale (NPRS-11), where 0 indicates no pain and 10 indicates the worst imaginable pain. This is the primary outcome measure.

Baseline (pre-intervention), 60 minutes after spinal joint manipulation, and 24 hours after spinal joint manipulation.

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Pressure pain threshold at lumbar levels L3-L5 measured by pressure algometry
Prazo: Baseline (pre-intervention), 60 minutes after spinal joint manipulation, and 24 hours after spinal joint manipulation.

Pressure pain threshold will be measured using a pressure algometer at lumbar levels L3, L4, and L5. Measurements will be taken over the spinous process and 2 cm laterally on both sides in the lumbar erector spinae region. Participants will indicate when pressure first becomes painful.

Baseline (pre-intervention), 60 minutes after spinal joint manipulation, and 24 hours after spinal joint manipulation.
Stress score on the 11-point Stress Numeric Rating Scale (SNRS-11)
Prazo: Baseline (pre-intervention), 60 minutes after spinal joint manipulation, and 24 hours after spinal joint manipulation.

Stress level will be assessed using the 11-point Stress Numeric Rating Scale (SNRS-11), where 0 indicates no stress and 10 indicates the highest stress level.

Baseline (pre-intervention), 60 minutes after spinal joint manipulation, and 24 hours after spinal joint manipulation.
Perceived stress score on the 10-item Perceived Stress Scale (PSS-10)
Prazo: Baseline (pre-intervention), 60 minutes after spinal joint manipulation, and 24 hours after spinal joint manipulation.

Perceived stress will be assessed using the 10-item Perceived Stress Scale (PSS-10), a licensed self-report questionnaire. Higher scores indicate greater perceived stress.

Baseline (pre-intervention), 60 minutes after spinal joint manipulation, and 24 hours after spinal joint manipulation.
Empathic concern score on the Interpersonal Reactivity Index
Prazo: Baseline (pre-intervention)

Empathy will be assessed using the Empathic Concern subscale of the Interpersonal Reactivity Index. Higher scores indicate greater empathic concern.

Baseline (pre-intervention)
Disability score related to low back pain on the Roland-Morris Disability Questionnaire
Prazo: Baseline (pre-intervention), 24 hours after spinal joint manipulation.

Disability related to low back pain will be assessed using a validated disability questionnaire for low back pain. Higher scores indicate greater disability.

Baseline (pre-intervention), 24 hours after spinal joint manipulation.
Kinesiophobia score on the Tampa Scale of Kinesiophobia
Prazo: Baseline (pre-intervention), 24 hours after spinal joint manipulation.

Kinesiophobia will be assessed using a validated self-report questionnaire evaluating fear of movement. Higher scores indicate greater fear of movement.

Baseline (pre-intervention), 24 hours after spinal joint manipulation.
Lumbar range of motion
Prazo: Baseline (pre-intervention), 60 minutes after spinal joint manipulation, and 24 hours after spinal joint manipulation.

Lumbar range of motion will be assessed using standardized clinical measurement procedures. Higher values indicate greater lumbar mobility.

Baseline (pre-intervention), 60 minutes after spinal joint manipulation, and 24 hours after spinal joint manipulation.
Lumbar tissue temperature measured by infrared thermography
Prazo: Baseline (pre-intervention), 60 minutes after spinal joint manipulation, and 24 hours after spinal joint manipulation.

Lumbar tissue temperature will be assessed in the lumbar region using standardized measurement procedures.

Baseline (pre-intervention), 60 minutes after spinal joint manipulation, and 24 hours after spinal joint manipulation.
Lumbar flexion and extension range of motion measured by Medi-Mouse
Prazo: Baseline (pre-intervention), 60 minutes after spinal joint manipulation, and 24 hours after spinal joint manipulation.

Lumbar range of motion will be assessed using the Medi-Mouse device. Lumbar flexion and extension will be measured using standardized procedures. Higher values indicate greater lumbar mobility.

Baseline (pre-intervention), 60 minutes after spinal joint manipulation, and 24 hours after spinal joint manipulation.
Expected treatment benefit score on a 0-100 Visual Analog Scale (VAS)
Prazo: Baseline (pre-intervention) and immediately after the observational learning procedure, before spinal joint manipulation.

Expected treatment benefit will be assessed using a self-report measure of the participants' expectations regarding the anticipated benefit of treatment. This measure will also be used to verify the immediate effect of the observational learning manipulation.

Baseline (pre-intervention) and immediately after the observational learning procedure, before spinal joint manipulation.
Fulfillment of treatment expectations score on a 0-100 Visual Analog Scale (VAS)
Prazo: 60 minutes after spinal joint manipulation and 24 hours after spinal joint manipulation.

Fulfillment of treatment expectations will be assessed using a self-report measure evaluating the extent to which treatment outcomes match prior expectations.

60 minutes after spinal joint manipulation and 24 hours after spinal joint manipulation.
Attitude toward manual therapy score on a 0-100 Visual Analog Scale (VAS)
Prazo: Baseline (pre-intervention)

Attitude toward treatment with manual therapy will be assessed using a Visual Analog Scale (VAS) from 0 to 100, where 0 indicates a very negative attitude and 100 indicates a very positive attitude. The participants will answer the question: "What is your attitude toward treatment with manual therapy?"

Baseline (pre-intervention)
Patient satisfaction score on an 11-point numeric rating scale
Prazo: 24 hours after spinal joint manipulation.

Patient satisfaction with treatment will be assessed using an 11-point numeric rating scale from 0 to 10, where 0 indicates "not satisfied at all" and 10 indicates "completely satisfied". The participants will answer the question: "Are you satisfied with the treatment you received?" Higher scores indicate greater satisfaction.

24 hours after spinal joint manipulation.

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
Inflammation-related blood biomarkers
Prazo: Baseline (pre-intervention), 60 minutes after spinal joint manipulation, and 24 hours after spinal joint manipulation.

Blood biomarkers related to inflammation will be analyzed, including interleukin-6 (IL-6), high-sensitivity C-reactive protein (hs-CRP), tumor necrosis factor alpha (TNF-α), and interleukin-10 (IL-10).

Baseline (pre-intervention), 60 minutes after spinal joint manipulation, and 24 hours after spinal joint manipulation.

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Investigadores

  • Cadeira de estudo: Kamil Zaworski, PhD, John Paul II University in Biała Podlaska

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

21 de abril de 2026

Conclusão Primária (Real)

7 de setembro de 2026

Conclusão do estudo (Real)

7 de setembro de 2026

Datas de inscrição no estudo

Enviado pela primeira vez

27 de março de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

27 de março de 2026

Primeira postagem (Real)

2 de abril de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

16 de outubro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

12 de outubro de 2026

Última verificação

1 de outubro de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • JohnPaul2U_KZ
  • SN.TJO-61.501.17.2025 (Número de outro subsídio/financiamento: John Paul II University in Biała Podlaska)

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

SIM

Descrição do plano IPD

De-identified individual participant data collected in this study will be made available to other researchers upon reasonable request. Shared data may include demographic and baseline characteristics, group allocation, outcome measures, and analyzable datasets related to pain intensity, disability, range of motion, psychological variables, pressure pain threshold, thermographic measures, and inflammatory biomarkers, after removal of direct identifiers.

Access Criteria:

Access to de-identified data will be granted to qualified researchers upon reasonable request to the principal investigator, subject to applicable ethics committee requirements, institutional policies, and confirmation that the proposed use is consistent with participant consent. A data access agreement may be required.

Prazo de Compartilhamento de IPD

Data will become available beginning 6 months after publication of the primary results and will remain available for 5 years thereafter.

Critérios de acesso de compartilhamento IPD

De-identified individual participant data and supporting documents will be made available to qualified researchers upon reasonable request to the principal investigator. Access will be granted for methodologically sound research purposes, subject to participant consent, ethics committee requirements, institutional policies, and, where applicable, a data access agreement.

Tipo de informação de suporte de compartilhamento de IPD

  • PROTOCOLO DE ESTUDO
  • SEIVA
  • ANALYTIC_CODE

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .